158 related articles for article (PubMed ID: 34218780)
1. The Absence of Myelin Basic Protein Reduces Non-Amyloidogenic Processing of Amyloid Precursor Protein.
Seiwa C; Sugiyama I; Sugawa M; Murase H; Kudoh C; Asou H
Curr Alzheimer Res; 2021; 18(4):326-334. PubMed ID: 34218780
[TBL] [Abstract][Full Text] [Related]
2. Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer's disease.
Boix CP; Lopez-Font I; Cuchillo-Ibañez I; Sáez-Valero J
Alzheimers Res Ther; 2020 Aug; 12(1):96. PubMed ID: 32787955
[TBL] [Abstract][Full Text] [Related]
3. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex.
Wu G; Sankaranarayanan S; Hsieh SH; Simon AJ; Savage MJ
J Neurosci Res; 2011 Jun; 89(6):822-32. PubMed ID: 21433051
[TBL] [Abstract][Full Text] [Related]
4. Myelin basic protein associates with AβPP, Aβ1-42, and amyloid plaques in cortex of Alzheimer's disease brain.
Zhan X; Jickling GC; Ander BP; Stamova B; Liu D; Kao PF; Zelin MA; Jin LW; DeCarli C; Sharp FR
J Alzheimers Dis; 2015; 44(4):1213-29. PubMed ID: 25697841
[TBL] [Abstract][Full Text] [Related]
5. Effects of TNFalpha-converting enzyme inhibition on amyloid beta production and APP processing in vitro and in vivo.
Kim ML; Zhang B; Mills IP; Milla ME; Brunden KR; Lee VM
J Neurosci; 2008 Nov; 28(46):12052-61. PubMed ID: 19005070
[TBL] [Abstract][Full Text] [Related]
6. Activated protein C inhibits amyloid β production via promoting expression of ADAM-10.
Li B; Yu D; Xu Z
Brain Res; 2014 Jan; 1545():35-44. PubMed ID: 24333930
[TBL] [Abstract][Full Text] [Related]
7. Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro.
Mei Z; Zhang F; Tao L; Zheng W; Cao Y; Wang Z; Tang S; Le K; Chen S; Pi R; Liu P
Neurosci Lett; 2009 Mar; 452(2):90-5. PubMed ID: 19154776
[TBL] [Abstract][Full Text] [Related]
8. The absence of myelin basic protein promotes neuroinflammation and reduces amyloid β-protein accumulation in Tg-5xFAD mice.
Ou-Yang MH; Van Nostrand WE
J Neuroinflammation; 2013 Nov; 10():134. PubMed ID: 24188129
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic acetylcholine receptor inhibition in transgenic Alzheimer-like Tg2576 mice by scopolamine favours the amyloidogenic route of processing of amyloid precursor protein.
Liskowsky W; Schliebs R
Int J Dev Neurosci; 2006; 24(2-3):149-56. PubMed ID: 16423497
[TBL] [Abstract][Full Text] [Related]
10. Evaluation and targeting of amyloid precursor protein (APP)/amyloid beta (Aβ) axis in amyloidogenic and non-amyloidogenic pathways: A time outside the tunnel.
Al-Kuraishy HM; Jabir MS; Al-Gareeb AI; Albuhadily AK; Albukhaty S; Sulaiman GM; Batiha GE
Ageing Res Rev; 2023 Dec; 92():102119. PubMed ID: 37931848
[TBL] [Abstract][Full Text] [Related]
11. Octyl gallate markedly promotes anti-amyloidogenic processing of APP through estrogen receptor-mediated ADAM10 activation.
Zhang SQ; Sawmiller D; Li S; Rezai-Zadeh K; Hou H; Zhou S; Shytle D; Giunta B; Fernandez F; Mori T; Tan J
PLoS One; 2013; 8(8):e71913. PubMed ID: 23977176
[TBL] [Abstract][Full Text] [Related]
12. Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease.
Dutescu RM; Li QX; Crowston J; Masters CL; Baird PN; Culvenor JG
Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1213-21. PubMed ID: 19271231
[TBL] [Abstract][Full Text] [Related]
13. Restoring Soluble Amyloid Precursor Protein α Functions as a Potential Treatment for Alzheimer's Disease.
Habib A; Sawmiller D; Tan J
J Neurosci Res; 2017 Apr; 95(4):973-991. PubMed ID: 27531392
[TBL] [Abstract][Full Text] [Related]
14. Diurnal patterns of soluble amyloid precursor protein metabolites in the human central nervous system.
Dobrowolska JA; Kasten T; Huang Y; Benzinger TL; Sigurdson W; Ovod V; Morris JC; Bateman RJ
PLoS One; 2014; 9(3):e89998. PubMed ID: 24646516
[TBL] [Abstract][Full Text] [Related]
15. Baicalein reduces β-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer's disease transgenic mouse model.
Zhang SQ; Obregon D; Ehrhart J; Deng J; Tian J; Hou H; Giunta B; Sawmiller D; Tan J
J Neurosci Res; 2013 Sep; 91(9):1239-46. PubMed ID: 23686791
[TBL] [Abstract][Full Text] [Related]
16. 7-Deoxy-trans-dihydronarciclasine Reduces β-Amyloid and Ameliorates Memory Impairment in a Transgenic Model of Alzheimer's Disease.
Chun YS; Zhang L; Li H; Park Y; Chung S; Yang HO
Mol Neurobiol; 2018 Dec; 55(12):8953-8964. PubMed ID: 29619739
[TBL] [Abstract][Full Text] [Related]
17. Effects of senescence and angiotensin II on expression and processing of amyloid precursor protein in human cerebral microvascular endothelial cells.
Sun R; He T; Pan Y; Katusic ZS
Aging (Albany NY); 2018 Jan; 10(1):100-114. PubMed ID: 29348391
[TBL] [Abstract][Full Text] [Related]
18. The orphan drug dichloroacetate reduces amyloid beta-peptide production whilst promoting non-amyloidogenic proteolysis of the amyloid precursor protein.
Parkin ET; Hammond JE; Owens L; Hodges MD
PLoS One; 2022; 17(1):e0255715. PubMed ID: 35025874
[TBL] [Abstract][Full Text] [Related]
19. Deletion of M1 muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo.
Davis AA; Fritz JJ; Wess J; Lah JJ; Levey AI
J Neurosci; 2010 Mar; 30(12):4190-6. PubMed ID: 20335454
[TBL] [Abstract][Full Text] [Related]
20. CNS amyloid-β, soluble APP-α and -β kinetics during BACE inhibition.
Dobrowolska JA; Michener MS; Wu G; Patterson BW; Chott R; Ovod V; Pyatkivskyy Y; Wildsmith KR; Kasten T; Mathers P; Dancho M; Lennox C; Smith BE; Gilberto D; McLoughlin D; Holder DJ; Stamford AW; Yarasheski KE; Kennedy ME; Savage MJ; Bateman RJ
J Neurosci; 2014 Jun; 34(24):8336-46. PubMed ID: 24920637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
